Sreevalsan Sreebhavan

A revised biosynthetic pathway for the cofactor F420 in prokaryotes

Ghader Bashiri, James Antoney, E.N.M. Jirgis et al. · Nature Communications · 2019 · 80 citations · Full text

Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs

Francis W. Hunter, Richard J. Young, Zvi Shalev et al. · Cancer Research · 2015 · 79 citations

Lipid Peroxidation, P450 Oxidoreductase, Pharmacotherapy +18

Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis

Jennifer A. Hollywood, Aneta Przepiorski, Randall F. D’Souza et al. · Journal of the American Society of Nephrology · 2020 · 79 citations · Full text

Bioavailable Blueberry‐Derived Phenolic Acids at Physiological Concentrations Enhance Nrf2‐Regulated Antioxidant Responses in Human Vascular Endothelial Cells

Jeffry S. Tang, Margreet C.M. Vissers, Robert F. Anderson et al. · Molecular Nutrition & Food Research · 2017 · 32 citations

Elongation of the Poly-γ-glutamate Tail of F420 Requires Both Domains of the F420:γ-Glutamyl Ligase (FbiB) of Mycobacterium tuberculosis

Ghader Bashiri, Aisyah Mohamed Rehan, Sreevalsan Sreebhavan et al. · Journal of Biological Chemistry · 2016 · 30 citations · Full text